Brief introduction of Shanghai Pharmaceutical Group:
Shanghai Pharmaceutical (Group) Co., Ltd. was established in June1996+1October 65438, formerly known as Shanghai Pharmaceutical (Group) Corporation, and its main business scope is the circulation of chemicals, biopharmaceuticals, traditional Chinese medicines and medicines.
Shanghai Pharmaceutical Group Co., Ltd. is a large pharmaceutical industry group listed in Shanghai and Hong Kong. The registered capital of the company is 2.842 billion yuan, and its main business covers pharmaceutical industry and commerce. The annual operating income of 202/kloc-0 is 2 158 billion yuan, ranking among Fortune Global 500 and 50 pharmaceutical companies in the world. China pharmaceutical companies rank second, and are selected into Shanghai Stock Exchange 180 Index, CSI 500 Index and MSCI.
The industrial manufacturing of Shanghai Pharmaceutical Group Company covers chemical and biological drugs, modern Chinese medicine health care products, medical devices and other fields. Its products cover seven therapeutic fields, such as anti-tumor, cardiovascular and cerebrovascular diseases, mental nerves, anti-infection, autoimmunity, digestion and metabolism, and respiratory system. It has established manufacturing bases in 65,438 provinces and cities in China and overseas, including characteristic raw materials bases, modern Chinese patent medicine bases, fine chemicals and biopharmaceuticals bases. The company's product specification is 65438.
Shanghai Pharmaceutical Co., Ltd. is the second largest pharmaceutical circulation enterprise and the largest service platform for imported drugs in China.